Zacks.com on MSN4d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
GlobalData on MSN4d
EC approves GSK’s Menveo vaccine presentation for IMD
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
PMLiVE3d
GSK granted EC approval for meningococcal disease vaccine Menveo
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
The Pharma Letter5d
EC nod for GSK’s Menveo meningococcal vaccine
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
GSK announces EC approved single-vial presentation of Menveo
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...
Daily3d
GSK fully liquid Menveo meningococcal vaccine approved by European Commission
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
Yahoo Finance4d
EC approves GSK’s Menveo vaccine presentation for IMD
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...
Nasdaq5d
GSK announces EC approved single-vial presentation of Menveo
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...